Literature DB >> 23294062

Biopolymer nanoparticle production for controlled release of biopharmaceuticals.

David Hudson1, Argyrios Margaritis.   

Abstract

For drug applications, nanoparticles, used as drug carriers, offer the advantage of controlled release, therapeutic impact and targeted delivery. In drug delivery applications, biodegradable polymers can be extracted from natural sources or prepared synthetically by polymerization. Natural polymers typically have varying compositions and physiochemical properties. As a result, methods which utilize natural polymers to encapsulate drugs are more varied and polymer dependent. The following polymers are discussed in this review article: alginate, chitosan, gelatin, albumin, gliadin, pullulan, and dextran. Specialized encapsulation nanotechnologies will be discussed such as ionotropic gelation, complexation, the reverse microemulsion technique, cross-linking methods, emulsion-dependent methods, desolvation methods and self-assembly methods. For each biopolymer an overview of the structure is presented with the corresponding encapsulation techniques. Understanding the structure of the biopolymer is important as to not only understand the rational for current encapsulation techniques but to continue to develop new encapsulation techniques in pursuit of the ideal drug carrier for application in therapeutic treatments.

Entities:  

Keywords:  Albumin; alginate; chitosan; complexation; desolvation; emulsification; encapsulation; gelatin; ionic gelation; pullulan

Mesh:

Substances:

Year:  2013        PMID: 23294062     DOI: 10.3109/07388551.2012.743503

Source DB:  PubMed          Journal:  Crit Rev Biotechnol        ISSN: 0738-8551            Impact factor:   8.429


  12 in total

Review 1.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

2.  In-fiber production of polymeric particles for biosensing and encapsulation.

Authors:  Joshua J Kaufman; Richard Ottman; Guangming Tao; Soroush Shabahang; Esmaeil-Hooman Banaei; Xiangdong Liang; Steven G Johnson; Yoel Fink; Ratna Chakrabarti; Ayman F Abouraddy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

3.  Aerosolized drug-loaded nanoparticles targeting migration inhibitory factors inhibit Pseudomonas aeruginosa-induced inflammation and biofilm formation.

Authors:  Mohammad Doroudian; Andrew O'Neill; Ciaran O'Reilly; Aisling Tynan; Leona Mawhinney; Aoife McElroy; Shanice S Webster; Ronan MacLoughlin; Yuri Volkov; Michelle E Armstrong; George A O'Toole; Adriele Prina-Mello; Seamas C Donnelly
Journal:  Nanomedicine (Lond)       Date:  2020-11-26       Impact factor: 5.307

Review 4.  Application of chitosan-based nanocarriers in tumor-targeted drug delivery.

Authors:  Mohammad Ali Ghaz-Jahanian; Farzin Abbaspour-Aghdam; Navideh Anarjan; Aydin Berenjian; Hoda Jafarizadeh-Malmiri
Journal:  Mol Biotechnol       Date:  2015-03       Impact factor: 2.695

5.  Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug.

Authors:  Simone A Costa; Davoud Mozhdehi; Michael J Dzuricky; Farren J Isaacs; Eric M Brustad; Ashutosh Chilkoti
Journal:  Nano Lett       Date:  2018-12-14       Impact factor: 11.189

6.  Mutant KRAS is a druggable target for pancreatic cancer.

Authors:  Elina Zorde Khvalevsky; Racheli Gabai; Itzhak Haim Rachmut; Elad Horwitz; Zivia Brunschwig; Ariel Orbach; Adva Shemi; Talia Golan; Abraham J Domb; Eylon Yavin; Hilla Giladi; Ludmila Rivkin; Alina Simerzin; Rami Eliakim; Abed Khalaileh; Ayala Hubert; Maor Lahav; Yael Kopelman; Eran Goldin; Alan Dancour; Yael Hants; Sagit Arbel-Alon; Rinat Abramovitch; Amotz Shemi; Eithan Galun
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

7.  Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.

Authors:  Jose Portilla-Arias; Rameshwar Patil; Hui Ding; Julia Y Ljubimova; Satoshi Inoue; Janet L Markman; Arthur Rekechenetskiy; Bindu Konda; Pallavi R Gangalum; Alexandra Chesnokova; Alexander V Ljubimov; Keith L Black; Eggehard Holler
Journal:  J Drug Target       Date:  2013-09-16       Impact factor: 5.121

Review 8.  Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments.

Authors:  Johan Karlsson; Hannah J Vaughan; Jordan J Green
Journal:  Annu Rev Chem Biomol Eng       Date:  2018-03-26       Impact factor: 11.059

Review 9.  Use of Nanoparticles in Tissue Engineering and Regenerative Medicine.

Authors:  Milad Fathi-Achachelouei; Helena Knopf-Marques; Cristiane Evelise Ribeiro da Silva; Julien Barthès; Erhan Bat; Aysen Tezcaner; Nihal Engin Vrana
Journal:  Front Bioeng Biotechnol       Date:  2019-05-24

Review 10.  Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications.

Authors:  Randy Chi Fai Cheung; Tzi Bun Ng; Jack Ho Wong; Wai Yee Chan
Journal:  Mar Drugs       Date:  2015-08-14       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.